ARGUN AKCAKANAT to MAP Kinase Signaling System
This is a "connection" page, showing publications ARGUN AKCAKANAT has written about MAP Kinase Signaling System.
Connection Strength
0.036
-
Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations. Sci Rep. 2022 01 24; 12(1):1248.
Score: 0.036
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.